2Rossini M, Gatti D, Isaia G, et al. Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism. J Bone Miner Res.2001,16( 1):113 - 119.
3Kakuta T, Fukagawa M, Fujisaki T, et al. Prognosis of parathyroid function aftr successful percutaneous ethanol injection therapy guided by color Doppler flow mapping in chronic dialysis patients. Am J Kidney Dis, 1999, 33(6) : 1091 - 1099.
1[1]Parfitt AM. The hyperparathyroidism of chronic renal failure: a disorder of growth[J]. Kidney Int, 1997,52:3-9.
2[2]Tominaga Y, Takagi. Molecular genetics of hyperparathyroidism disease[J]. Curr Opin Nephrol Hypertens, 1996,5:336-341.
3[3]Armold A, Brown MF, Urena P, et al. Monoclonlity of p arathyroid tumors in chronic renal failure and in primary parathyroid hyperpalasia[J]. J Clin Invest, 1995,95:2047-2053.
4[4]Tominaga Y, Takagi H. Molecular genetics of hyperparathyroidism disease[J]. Curr Opin Nephrol Hypertens,1996,5:336-341.
5[5]Muller H, Lukas J, Schneider A, et al. Cyclin D1 expression is regulated by the retinoblastoma protein[J]. Proc Natl Acad Sci USA, 1994, 91:2945-2948.
6[6]Fujisaki T, Hida M, Hiraga S, et al. Cellular proliferation and secretion in secondary hyperparathyroidism[J]. Nephron, 1997,776:68-75.
7Zhou JP, Li YJ, Dong M, et al. Localizing diagnosis of primary hyperparathyroidism[J]. Chin J Gen Surg, 2005, 20(4): 227.
8Meola M, Petrucci I, Colombini E, et al. Use of ultrasound to assess the response to therapy for secondary hyperparathyroidism[J]. Am J Kidney Dis, 2011, 58(3): 485-491.
9Vulpio C, Bossola M, Magalini SC, et al. Parathyroid-gland ultrasonography in clinical and therapeutic evaluation of renal secondary hyperparathyroidism[J]. Radiol Med, 2013, 118(5): 707-722.
10Mohammadi A, Moloudi F, Ghasemi-rad M, et al. Spectral Doppler analysis of parathyroid adenoma: Correlation between resistive index and serum parathyroidhormone concentration[J]. AJR Am J Roentgenol, 2013, 201 (2): 318-321.
